Literature DB >> 1280592

Pharmacological characterization of new cholecystokinin analogues.

L Maletínská1, M F Lignon, M C Galas, N Bernad, J Pírková, J Hlavácek, J Slaninová, J Martinez.   

Abstract

New analogues of cholecystokinin-7 (CCK-7) modified at amino acid residues 5 and 7 were assayed for their effect on gall bladder, pancreatic secretion, food intake (anorectic activity), amount of rearing (sedative activity) and analgesia, as well as their ability to inhibit 125I-CCK-8 binding to pancreatic cell membrane receptors and brain membrane receptors. The results were compared to the activities of standard compounds, CCK-8, cerulein, BOC-CCK-7 (BOC = tertbutyloxycarbonyl) and BOC-[Nle2,Nle5]CCK-7. All analogues exhibited agonistic effects. Their anorectic activity was significantly prolonged.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280592     DOI: 10.1016/0014-2999(92)90861-w

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Utilization of some non coded amino acids as isosters of peptide building blocks.

Authors:  J Hlaváček; R Marcová; R Ježek; J Slaninová
Journal:  Amino Acids       Date:  1996-09       Impact factor: 3.520

2.  Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration.

Authors:  L Maletínská; V Nagelová; A Tichá; J Zemenová; Z Pirník; M Holubová; A Špolcová; B Mikulášková; M Blechová; D Sýkora; Z Lacinová; M Haluzík; B Železná; J Kuneš
Journal:  Int J Obes (Lond)       Date:  2015-03-16       Impact factor: 5.095

3.  Cholecystokinin system is involved in the anorexigenic effect of peripherally applied palmitoylated prolactin-releasing peptide in fasted mice.

Authors:  Z Pirník; L Kořínková; J Osacká; B Železná; J Kuneš; L Maletínská
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.